Kinomics Screening Identifies Aberrant Phosphorylation of CDC25C in FLT3-ITD-positive AML.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Anticancer Research

• Publication date

  2016-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.21873/ANTICANRES.11219PMID 27919943
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivo

  2016cited by this paper
• Genomic Classification and Prognosis in Acute Myeloid Leukemia.

  2016cited by this paper
• Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C

  2016cited by this paper
• AML evolution from preleukemia to leukemia and relapse.

  2015cited by this paper
• CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia

  2015cited by this paper
• Phospho-Cdc25 correlates with activating G2/M checkpoint in mouse zygotes fertilized with hydrogen peroxide-treated mouse sperm

  2014cited by this paper
• Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia — The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms

  2014cited by this paper
• Abstract 3439: Recurrent CDC25C mutations drive malignant transformation in FPD/AML

  2014cited by this paper
• Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

  2013cited by this paper
• Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML.

  2012cited by this paper
• Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα.

  2012cited by this paper
• Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide

  2011cited by this paper
• All hematopoietic cells develop from hematopoietic stem cells through Flk2/Flt3-positive progenitor cells.

  2011cited by this paper
• Direct roles of the signaling kinase RSK2 in Cdc25C activation during Xenopus oocyte maturation

  2010cited by this paper
• A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide

  2009cited by this paper
• MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment

  2008cited by this paper
• Characterization of centrosomal localization and dynamics of Cdc25C phosphatase in mitosis

  2008cited by this paper
• Aberrant pre-mRNA splicing of a highly conserved cell cycle regulator, CDC25C, in myelodysplastic syndromes

  2008cited by this paper
• Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition.

  2007cited by this paper
• CDC25 phosphatases in cancer cells: key players? Good targets?

  2007cited by this paper
• The when and wheres of CDC25 phosphatases.

  2006cited by this paper
• Plk1 promotes nuclear translocation of human Cdc25C during prophase

  2002cited by this paper
• Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

  2002cited by this paper
• Absence of Apparent Phenotype in Mice Lacking Cdc25C Protein Phosphatase

  2001cited by this paper
• Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

  1999cited by this paper
• Ectopic Expression of Cdc25A Accelerates the G1/S Transition and Leads to Premature Activation of Cyclin E- and Cyclin A-Dependent Kinases

  1999cited by this paper
• Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

  1997cited by this paper
• Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.

  1996cited by this paper
• Activation of p34cdc2 protein kinase by microinjection of human cdc25C into mammalian cells. Requirement for prior phosphorylation of cdc25C by p34cdc2 on sites phosphorylated at mitosis.

  1994cited by this paper
• cdc25 M-phase inducer.

  1991cited by this paper

• A novel quinoid-based CDC25 phosphatase inhibitor against human lung adenocarcinoma across different models.

  2025cites this paper
• BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway

  2025cites this paper
• How ITD Insertion Sites Orchestrate the Biology and Disease of FLT3-ITD-Mutated Acute Myeloid Leukemia

  2023cites this paper
• α-Mangostin and Doxorubicin Combination Synergistically Inhibited Cell Growth, Induced Cell Apoptosis with Increased Bak Protein and Decreased FLT3-ITD Phosphorylation in AML MOLM-13 Cell Line

  2021cites this paper
• Lamprey Prohibitin2 Arrest G2/M Phase Transition of HeLa Cells through Down-regulating Expression and Phosphorylation Level of Cell Cycle Proteins

  2018cites this paper
• Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study

  2018cites this paper
• FLT3–ITD and its current role in acute myeloid leukaemia

  2017cites this paper